Basal cell carcinoma (BCC) is the most common skin cancer. Metastatic BCC is rare (0,0028% to 0,5%), with a very poor prognosis, survival rates of 3 years, in cases of locoregional lymphatic metastases,is estimated at 8 months. For this form of basal cell carcinoma,treatment is based on surgery and radiotherapy, chemotherapy bye Platinum-based or the inhibitors of the Hedgehog vismodegibcan be used for non-operative patients. We report a case of a 41 years old male man who suffered from BCC on his right cheek with lymph node metastases.
Alan : Sosyal, Beşeri ve İdari Bilimler
Dergi Türü : Uluslararası
Benzer Makaleler | Yazar | # |
---|
Makale | Yazar | # |
---|